Taiwan approves Gilead's remdesivir to treat COVID-19
Taiwan`s government said on Saturday it had approved Gilead Sciences` potential COVID-19 treatment, remdesivir, to treat the illness caused by the novel coronavirus.
Governments are racing to bolster supplies of remdesivir, which U.S. regulators this month approved for emergency use. Photo: Reuters